Javascript must be enabled to continue!
Abstract GS.09: Interleukin 13 Signaling To Macrophages Promotes Recovery After Myocardial Infarction In Mice
View through CrossRef
Introduction:
There is great interest in identifying signaling pathways that promote pro-reparative macrophage phenotypes in the heart. Considering the remarkable cardiac healing potential of neonatal mice, we employ this model to identify pro-reparative mechanisms that can be applied to promote cardiac repair in adults after myocardial infarction (MI). We show that IL13/IL4Rα signaling specifically on macrophages mediates neonatal heart regeneration and activation of this pathway in adult mice promotes cardiac functional recovery in post-MI.
Results:
We developed IL4Rα
fl/fl
;CX3CR1
Cre
mice (IL4Rα
MacKO
) to delete IL4Rα specifically in macrophages. Neonatal IL4Rα
MacKO
and control mice were subjected to MI on postnatal day 1 (P1). Following injury, IL4Rα
MacKO
mice had significantly larger scars at 8 days post injury (dpi) and lower ejection fraction and capillary density at 21 dpi. Thus, macrophage IL4Rα expression is critical for cardiac functional recovery following injury in neonates. Using fluorescent reporter mice, we found that IL13, a ligand for IL4Rα, is produced almost exclusively by type 2 innate lymphoid cells in the neonatal heart. Interestingly, we didn’t find any cellular source of IL13 in the adult mouse heart. Considering the decline in cardiac production of IL13 from neonatal to adult stages, we postulated that reactivation of IL4Rα in the adult heart would improve cardiac healing post MI in adults. Indeed, daily IL13 administration significantly improved cardiac function post MI in adult mice, and this improvement was mediated entirely by IL4Rα expression on macrophages as IL4Rα
MacKO
mice showed no functional improvement with IL13 administration. Intriguingly, while IL13 administration to control mice improved cardiac function, administration to IL4Rα
MacKO
mice further exacerbated post MI mortality and scar size compared to animals receiving PBS, suggesting multiple cardiac cell types respond to IL13 resulting in beneficial or detrimental outcomes.
Conclusions:
Our data elucidates a strongly pro-reparative role for IL13 signaling directly to macrophages. While this signaling pathway is active in neonatal stages, we demonstrate that re-activation by IL13 administration is required to promote cardiac repair in adults.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract GS.09: Interleukin 13 Signaling To Macrophages Promotes Recovery After Myocardial Infarction In Mice
Description:
Introduction:
There is great interest in identifying signaling pathways that promote pro-reparative macrophage phenotypes in the heart.
Considering the remarkable cardiac healing potential of neonatal mice, we employ this model to identify pro-reparative mechanisms that can be applied to promote cardiac repair in adults after myocardial infarction (MI).
We show that IL13/IL4Rα signaling specifically on macrophages mediates neonatal heart regeneration and activation of this pathway in adult mice promotes cardiac functional recovery in post-MI.
Results:
We developed IL4Rα
fl/fl
;CX3CR1
Cre
mice (IL4Rα
MacKO
) to delete IL4Rα specifically in macrophages.
Neonatal IL4Rα
MacKO
and control mice were subjected to MI on postnatal day 1 (P1).
Following injury, IL4Rα
MacKO
mice had significantly larger scars at 8 days post injury (dpi) and lower ejection fraction and capillary density at 21 dpi.
Thus, macrophage IL4Rα expression is critical for cardiac functional recovery following injury in neonates.
Using fluorescent reporter mice, we found that IL13, a ligand for IL4Rα, is produced almost exclusively by type 2 innate lymphoid cells in the neonatal heart.
Interestingly, we didn’t find any cellular source of IL13 in the adult mouse heart.
Considering the decline in cardiac production of IL13 from neonatal to adult stages, we postulated that reactivation of IL4Rα in the adult heart would improve cardiac healing post MI in adults.
Indeed, daily IL13 administration significantly improved cardiac function post MI in adult mice, and this improvement was mediated entirely by IL4Rα expression on macrophages as IL4Rα
MacKO
mice showed no functional improvement with IL13 administration.
Intriguingly, while IL13 administration to control mice improved cardiac function, administration to IL4Rα
MacKO
mice further exacerbated post MI mortality and scar size compared to animals receiving PBS, suggesting multiple cardiac cell types respond to IL13 resulting in beneficial or detrimental outcomes.
Conclusions:
Our data elucidates a strongly pro-reparative role for IL13 signaling directly to macrophages.
While this signaling pathway is active in neonatal stages, we demonstrate that re-activation by IL13 administration is required to promote cardiac repair in adults.
Related Results
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
Objectives
To investigate the clinical value of myocardial enzymes and troponin I combined detection for early diagnosis of acute myocardial infarction.
...
Abstract 118: Interleukin 4 And 13 Signaling In Macrophages Regulates Neonatal Cardiac Regeneration
Abstract 118: Interleukin 4 And 13 Signaling In Macrophages Regulates Neonatal Cardiac Regeneration
Introduction:
Heart failure (HF) is a prevalent disease, projected to affect over 8 million Americans by 2030. Current therapy partially decreases progression; however,...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Relation between Interleukin-6, Interleukin-10 and Interleukin-2 Receptor and mortality in Severely Ill COVID-19 patients
Relation between Interleukin-6, Interleukin-10 and Interleukin-2 Receptor and mortality in Severely Ill COVID-19 patients
Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infe...
IL‐3 is an important differentiation factor for the development of prostaglandin E2‐producing macrophages between C57BL/6 and BALB/c mice
IL‐3 is an important differentiation factor for the development of prostaglandin E2‐producing macrophages between C57BL/6 and BALB/c mice
AbstractWe have previously reported that peritoneal and splenic macrophages from Th2‐dominant BALB/c mice produced higher amounts of prostaglandin (PG) E2 than cells from C57BL/6 m...
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
Objectives
Low density lipoprotein receptor defect mice model by transgenetic technology was used to detect atherosclerosis by Ultrasound Biology (UBM). And evalu...
CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages
CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages
Background:
Angiogenesis in atherosclerotic plaque is an important factor causing plaque hemorrhage, vulnerability, and rupture, and different phenotypes of macrophages...
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.
The time of acute myocardial infarction was determined in all 1,741 patients of the ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study, based on onset of clinica...

